Orion S.A., together with its subsidiaries, engages in the manufacture and sale of carbon black products. The company operates in two segments, Specialty Carbon...
Analyst Maintains Buy on iX Biopharma, Sees Post-FY26 Transition Driving Strong FY27+ Rebound and Keeps DCF-Based S$1.00 Target Price
OEC: Global carbon black leader with resilient earnings, strong cash flow, and high-growth outlook
Orion S.A. (NYSE:OEC) Receives Consensus Recommendation of "Strong Sell" from Brokerages
Orion S.A. to Participate in Upcoming Investor Conferences | OEC Stock News